You are receiving this email because you are subscribed to Daily Insider Trades. If you no longer wish to receive these emails, please unsubscribe here. |
|
|
Targeting stocks with recently announced buyback programs can increase returns significantly, especially when pursued consistently over time.
With a buyback, companies may increase both earnings per share and potential upside by decreasing the total supply of outstanding shares. It can also indicate a company's confidence in their own stock value.
Here are three notable recent stock buybacks - |
Pacira BioSciences, Inc. – SYM: PCRX
Recent Price: $25.83
Buyback Action: The Board of Directors approved a new $300 million share repurchase program, equal to around 26.3% of its market cap at announcement.
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. The company has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida. |
I won't take up much of your time...
But I wanted to get this message out to you ASAP.
I've released my newest gold recommendation.
This undervalued miner is currently trading for about $0.40 per share...
And, based on my market analysis, has the potential to generate a 25X return.
Click here to be one of the 1st to get this information.
I go into much more detail in the short video below...
|
Equifax Inc. – SYM: EFX
Recent Price: $249.28
Buyback Action: Buyback Action: The Board of Directors announced that it had approved a new $3 billion share repurchase program, equal to around 9.65% of its market cap at announcement.
Equifax Inc. operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that that assist them in complying with and automating certain payroll-related and human resource management processes throughout the entire cycle of the employment relationship. The U.S. Information Solutions segment provides consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting services; mortgage services; financial marketing services; identity management services; and credit monitoring products. The International segment offers information service products, which include consumer and commercial services, such as credit and financial information, and credit scoring and modeling; and credit and other marketing products and services, as well as offers information, technology, and services to support debt collections and recovery management. It also provides information solutions for businesses, governments and consumers; and human resources business process automation and outsourcing services for employers.It operates in Argentina, Australia, Brazil, Canada, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Honduras, India, Ireland, Mexico, New Zealand, Paraguay, Peru, Portugal, Spain, the United Kingdom, Uruguay, and the United States. The company was founded in 1899 and is headquartered in Atlanta, Georgia.
Click here to continue reading the full article and see our last pick. |
|
|
Our mailing address is:
DC2 Publishing LLC
4260 NW 1st Avenue Suite # 55
Boca Raton, FL 33431 - 4264 Daily Insider Trades
Copyright © 2025 DC2 Publishing LLC, All rights reserved.
You're receiving this email as part of your subscription to Daily Insider Trades. For more information about our privacy practices, please review our Privacy Policy or our Terms of Use.
|
|
|
|
Post a Comment
Post a Comment